Jay Shepard

Jay Shepard

Director/Board Member bei ESPERION THERAPEUTICS, INC.

Vermögen: 1 Mio $ am 31.03.2024

66 Jahre
Health Technology
Finance
Consumer Services

Profil

Jay P.
Shepard
was the founder of Relypsa, Inc. (founded in 2007) and held the title of Director from 2008 to 2010.
Mr. Shepard is also the founder of Pathalys Pharma, Inc. Mr. Shepard's current job(s) include being an Independent Director at Esperion Therapeutics, Inc. since 2018, an Independent Director at Ironwood Pharmaceuticals, Inc. since 2020, a Director at Santa Clara University, an Independent Director at Inovio Pharmaceuticals, Inc. since 2020, a Director at Craig Hospital, an Independent Director at Altamont Pharma Acquisition Corp., an Outside Director at Aculys Pharma LLC, a Director at Cessation Therapeutics, LLC, and a Venture Partner at Catalys Pacific LLC.
Mr. Shepard's former job(s) include being the President, Chief Executive Officer & Director at NextWave Pharmaceuticals, Inc. from 2011 to 2012, the President, Chief Executive Officer & Director at Ilypsa, Inc. from 2005 to 2007, the President, CEO, CFO & Director at Versartis, Inc. from 2017 to 2018, the Chairman at Aravive, Inc. in 2020, a Director at InterMune, Inc., an Independent Director at DURECT Corp., an Independent Director at Marinus Pharmaceuticals, Inc., a Director at Sorbent Therapeutics, Inc., a Director at Bullet Biotechnology, Inc., a Director at Christopher & Dana Reeve Foundation from 2016 to 2020, a Director at NeuroRecovery Technologies, Inc., a Vice President at ALZA Corp., the Vice President-Commercial Operations at Telik, Inc. from 2001 to 2005, an Executive Partner at Sofinnova Investments, Inc. from 2008 to 2015, a Principal at Syntex Laboratories, Inc., the Vice President-Oncology Business Unit at ALZA Pharmaceuticals from 1993 to 2000, and a Principal at Ortho Pharmaceutical Corp.
Mr. Shepard's education history includes undergraduate studies at the University of Arizona.
Mr. Shepard is also the founder of Pathalys Pharma, Inc...

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
20.06.2023 102 244 ( 0,07% ) 890 545 $ 31.03.2024
15.06.2023 28 599 ( 0,02% ) 76 645 $ 31.03.2024
16.11.2023 4 877 ( 0,02% ) 67 693 $ 31.03.2024

Aktive Positionen von Jay Shepard

UnternehmenPositionBeginn
ESPERION THERAPEUTICS, INC. Director/Board Member 29.05.2018
INOVIO PHARMACEUTICALS, INC. Director/Board Member 15.01.2020
IRONWOOD PHARMACEUTICALS, INC. Director/Board Member 03.12.2020
Santa Clara University Director/Board Member -
Private Equity Investor -
Director/Board Member -
Founder -
Director/Board Member -
Director/Board Member -
░░░░░░░░░ ░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░ -
Alle aktiven Positionen von Jay Shepard

Ehemalige bekannte Positionen von Jay Shepard

UnternehmenPositionEnde
░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░ ░░░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Jay Shepard im Detail an

Ausbildung von Jay Shepard

University of Arizona Undergraduate Degree

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Jay Shepard im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

30

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen6
ESPERION THERAPEUTICS, INC.

Health Technology

DURECT CORPORATION

Health Technology

IRONWOOD PHARMACEUTICALS, INC.

Health Technology

MARINUS PHARMACEUTICALS, INC.

Health Technology

INOVIO PHARMACEUTICALS, INC.

Health Technology

ARAVIVE, INC.

Health Technology

Private Unternehmen22

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Christopher & Dana Reeve Foundation

Miscellaneous

Syntex Laboratories, Inc.

Health Technology

ALZA Pharmaceuticals

Ortho Pharmaceutical Corp.

Health Services

Health Technology

Health Technology

Finance

Finance

Sofinnova Ventures

Health Technology

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Jay Shepard